Form 4: Gilead Sciences EVP Deborah Telman Reports Stock Transactions
SEC Form 4 Filing
Deborah H. Telman, EVP, Corporate Affairs & GC of Gilead Sciences, reports the disposition and acquisition of common stock and restricted stock units on July 25, 2024.
Summary
- On July 25, 2024, Deborah H. Telman, EVP, Corporate Affairs & GC of Gilead Sciences, reported transactions involving Gilead Sciences common stock and restricted stock units.
- Telman disposed of 2,917 shares of common stock at a price of $76.51.
- She also acquired 514 and 8,230 shares of common stock through the vesting of restricted stock units.
- Following these transactions, Telman directly owns 20,375 shares of Gilead Sciences common stock.
- She also holds 30,186 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.
Stakeholder Impact
- The transactions may provide insights to stakeholders regarding management's perspective on the company's stock value.
Key Dates
| Date | Description |
|---|---|
| 07/25/2024 | Date of earliest transaction: disposition and acquisition of common stock and restricted stock units. |
| 07/26/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.